Many think on here that I exaggerate my sp and MC
predictions:
Let me explain
A phase 2b molecule is worth in excess of $285 million
That’s around 35c per share
So IF our Tox and DMD is successful( ( meaning we replicate our end points PUL 2.0)
We move to a Phase 3
A molecule in P3 is worth $1248 million
The interesting thing here is .. that if the DMD results are better than expected PER w
ill go to the FDA .. for going into commercialisation $$
Once we get the green light from the FDA
PER has stated we could have a market of $1 billion US per annum and that’s only in DMD..
n
per-chart, page-609
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.91M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.4¢ | 7.0¢ | $17.78K | 246.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13800 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.4¢ | 63495 | 1 |
View Market Depth
| Last trade - 15.22pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.4¢ |
Change
0.000 ( 2.78 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.4¢ | 7.0¢ | 44500 | ||
| Last updated 14.24pm 27/05/2024 ? | |||||
| PER (ASX) Chart |